Novel immunological strategies for HIV-1 eradication

Por Jülg, B, Barouch, DH
Publicado no J Virus Erad (2015)

P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes

Por Barouch DH, Simmons NL, Kaufman DR
Publicado em 2009-10-01

P17-13. Hexon hypervariable regions 4–7 contain important Ad5-specific neutralizing antibody epitopes

Por Bradley, RR, Maxfield, LF, Barouch, DH
Publicado em 2009

P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes

Por Kaufman, DR, Simmons, NL, Barouch, DH
Publicado em 2009

Development of replication-competent adenovirus based vaccine vectors

Por Abbink, P, Maxfield, LF, Barouch, DH
Publicado em 2012

Adenovirus vectors from various serotypes induce distinct cytokine profiles

Por Teigler, JE, Iampietro, M, Barouch, DH
Publicado em 2012

Nonreplicating vectors in HIV vaccines

Por Johnson, JA, Barouch, DH, Baden, LR
Publicado em 2013

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys

Por Liu J, Li H, Iampietro M, Barouch DH
Publicado em 2012-09-01

P10-06. Adaptive immune responses elicited by recombinant adenovirus vectors exhibit partial MyD88 dependence

Por Rhee, EG, Kasturi, SP, Pulendran, B, Barouch, DH
Publicado em 2009

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys

Por Liu, J, Li, H, Iampietro, M, Barouch, DH
Publicado em 2012

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys

Por Stephenson, KE, Li, H, Walker, BD, Michael, NL, Barouch, DH
Publicado em 2012

Humoral immune response profiling with peptide microarrays

Por Reimer U, Wenschuh H, Baden LR, Pau M, Weijtens M, Barouch DH
Publicado em 2012-09-01

Humoral immune response profiling with peptide microarrays

Por Reimer, U, Wenschuh, H, Baden, LR, Pau, M, Weijtens, M, Barouch, DH
Publicado em 2012

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Por Li H, Rhee EG, Masek-Hammerman K, Teigler JE, Abbink P, Barouch DH
Publicado em 2012-09-01

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Por Li, H, Rhee, EG, Masek-Hammerman, K, Teigler, JE, Abbink, P, Barouch, DH
Publicado em 2012

Development of a novel simian adenovirus 24 based vaccine vector

Por Abbink, P, Bradley, RR, Ball, F, Ng'ang'a, D, Borducchi, E, Barouch, DH
Publicado em 2012

Full-length HIV-1 immunogens induce greater T lymphocyte responses to conserved epitopes than conserved-region-only HIV-1 immunogens in monkeys

Por Stephenson, KE, SanMiguel, A, Simmons, NL, Smith, K, Szinger, JJ, Korber, BT, Barouch, DH
Publicado em 2012

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses

Por Penaloza P, Borducchi E, McNally A, Simmons N, Teigler J, Provine N, Tan W, Ahmed R, Barouch DH
Publicado em 2012-09-01

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses

Por Penaloza, P, Borducchi, E, McNally, A, Simmons, N, Teigler, J, Provine, N, Tan, W, Ahmed, R, Barouch, DH
Publicado em 2012

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study

Por Maxfield, LF, King, SL, Riggs, AM, Dilan, R, LaPorte, A, Hural, J, McElrath, MJ, Goudsmit, J, Barouch, DH
Publicado em 2009